Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingzong Li

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Cancer Therapeutics|August 17, 2016
Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast CancerKatarzyna A Ludwik, J Preston Campbell, Mingzong Li, et al.
Journal of Medicinal Chemistry|March 16, 2022
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious LeadsMingzong Li, Zenon Konteatis, Nelamangala Nagaraja, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Cancer Therapeutics|August 17, 2016
Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast CancerKatarzyna A Ludwik, J Preston Campbell, Mingzong Li, et al.
Journal of Medicinal Chemistry|March 16, 2022
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious LeadsMingzong Li, Zenon Konteatis, Nelamangala Nagaraja, et al.
Pageof 2